Third Party Funding
- DFG SFB_TR36
- German Center for Infection Research (DZIF)
- Helmholtz Alliances “Immunotherapy of Cancer” and „Synthetic Biology“
- Helmholtz-Alberta Initiative on Infection Research
- Helmholtz Validation Fond
- Innovation Funds, Federal Ministry for Economic Affairs Germany
Industry research collaborations:
- Roche Inc., Paolo Alto, CA, USA
- Janssen Pharmaceutica, Beerse, Belgium
- GILEAD Sciences, Foster City, USA
- Leukocare, Munich
- Rheinbiotech – Dynavax Europe, Düsseldorf, Germany
